Ledger.Open graph →

SEC Form D · filed February 21, 2019

Bryn Pharma, LLC

Offering

$18.0M

Sold

$17.2M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

RALEIGH, NC

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Kate Grell · Raleigh, NCDirector Steven Hartman · Raleigh, NCExec · Director Stephen Beckman · Raleigh, NCExec David Dworaczyk · Raleigh, NCExec · Director Michelle Lobel · Raleigh, NCExec · Director Martin Devenport · Rockville, MDExec · Director Rajul Garg · Singapore, U0Exec · Director Avrohom G. Vann · Evanston, ILExec Miao Hong · Rockville, MDDirector Kun-Liang Guan · Rockville, MDExec · Director Swan E. Sit · EMERYVILLE, CAExec · Director Xiaopei (Ray) Wang · EMERYVILLE, CAExec · Director Yenyou (Jeff) E. Zheng · EMERYVILLE, CADirector Paul E. Freiman · EMERYVILLE, CAExec Andrew M. Jones · EMERYVILLE, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗